Simplex Trading
KZIA

Simplex Trading’s Kazia Therapeutics KZIA Stock Holding History

Simplex Trading’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed – – 9239
2025
Q1 		$0 Sell
1
-141
-99% -$834 ﹤0.01% 9108
2024
Q4 		$1K Buy
142
+132
+1,320% +$3.05K ﹤0.01% 8235
2024
Q3 		$0 Buy
+10
New +$200 ﹤0.01% 9060
2024
Q1 		– Sell
-4
Closed – – 9374
2023
Q4 		$0 Buy
+4
New +$117 ﹤0.01% 9361
2022
Q3 		– Sell
-20
Closed -$4K – 10435
2022
Q2 		$4K Sell
20
-78
-80% -$23.9K ﹤0.01% 8988
2022
Q1 		$37K Sell
98
-52
-35% -$18.6K ﹤0.01% 7538
2021
Q4 		$63K Buy
150
+58
+63% +$28.9K ﹤0.01% 6916
2021
Q3 		$44K Hold
92
– – ﹤0.01% 7657
2021
Q2 		$45K Buy
+92
New +$48.5K ﹤0.01% 7774
2021
Q1 		– Sell
-71
Closed -$37.1K – 9442
2020
Q4 		$30K Buy
+71
New +$28.3K ﹤0.01% 6666

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Simplex Trading's KZIA Position: Q2 2025 in Review

Simplex Trading sold out of Kazia Therapeutics (KZIA) in Q2 2025, closing a stake of 1 share.

Simplex Trading first reported a position in KZIA in Q4 2020 and held it in 10 quarters. The position peaked at $63K in Q4 2021. 10 funds tracked by Wall St. Rank hold KZIA as of Q2 2025.

  • Simplex Trading reported no remaining Kazia Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 1 Kazia Therapeutics share in Q2 2025.
  • Simplex Trading first reported a position in Kazia Therapeutics in Q4 2020 and held it in 10 quarters.
  • Simplex Trading's Kazia Therapeutics position peaked at $63K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.